We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis (ULTRA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03711448
Recruitment Status : Recruiting
First Posted : October 18, 2018
Last Update Posted : October 14, 2022
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire Dijon

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2025
Estimated Study Completion Date : January 2025